HLE Glascoat Ltd Q2 FY2026 Concall Summary

Key Takeaways

• Margins troughed, recovery is priced in: Q2 was the bottom quarter, with EBITDA margins expected to rebound to ~16% in H2 as higher-margin orders flow through and Omeras losses fade.
• Glass line margins are a lagging indicator: Competitive pricing on past orders and initial Omeras losses compressed margins, but new orders carry better pricing and will hit the P&L only in Q4 given the 5–7 month lag.
• Filtration & drying is the silent outperformer: The business has already crossed ₹35 crores in EBIT for H1, nearly matching full-year FY25, and is on track for all-time records.
• Omeras is a breakeven story for now: The German acquisition posted a ₹3.6 crore EBIT loss this quarter, but management expects breakeven or better by year-end, with healthy double-digit EBIT margins once volumes build.
• What to watch next quarter: Whether the 80% glass line capacity utilization target for Q4 stays on track, the pace of Omeras inquiry-to-order conversion from its EUR 28 million pipeline, and whether H2 revenue follows the historical 55–60% pattern.

The Margin Story: Why Q2 Was the Bottom

• Glass line segment hit twice: Margins were compressed by competitive pricing on large projects won in prior quarters to rebuild volumes, plus a ₹3.6 crore EBIT loss from the newly acquired Omeras business in Germany. India glass line margins ex-Omeras remain stable.
• The lag mechanism: Orders booked today take 5–7 months to reflect in the P&L, so better margins currently being negotiated will appear only in Q4. The margin rebuild is a function of volume recovery and capacity utilization, not structural change.
• H2 EBITDA target: Management expects overall EBITDA margins of roughly 16% in H2, a material step-up from the first half. Full-year PAT margin is guided at 6.5–7%.
• Q2 confirmed as trough: Management agreed it is a fair assumption that Q2 was the bottom quarter.

Nilesh Ganjwala: "So the better margins that we are currently in a position to negotiate will reflect in the P&L only in quarter 4, which is exactly what I had indicated in my earlier answer."

Segment Health: A Mixed Portfolio

• End-market demand: Pharma API is doing well with good orders. Techchem is improving but not fully back. Agrochemical remains under pressure. Overall sentiment is encouraging, though some players have slowed capex since August due to U.S. tariff uncertainty on India.
• Competitive intensity: Glass line is slightly more competitive than filtration & drying. Heat exchanger faces lower intensity due to a larger addressable market.

Nilesh Ganjwala: "I think it is unlikely to be high double digits in a hurry. Obviously, these businesses take a little time. We are -- the Thaletec business is nice and stable. It's the India glass line business, which needs to be built up."

Omeras: The New Variable

• Acquisition complete: No remaining formalities; the business is fully integrated from an implementation perspective.
• Early execution: Delivered EUR 1.8 million of goods in the first 45 days. Some orders (about \$0.5 million) were canceled as non-viable, consistent with due diligence findings. Current order book is a marginal EUR 4–4.5 million.
• Pipeline vs conversion: Inquiry visibility stands at EUR 28 million, up a couple of million from 45 days ago, but conversion is still awaited. Some are large projects that will convert in one go, and relationship building with new management is ongoing.
• Margin trajectory: Currently at ~5% EBITDA; management is very confident of achieving projected acquisition numbers. Healthy double-digit EBIT margins are expected once volumes reach optimal levels. Breakeven or better by FY26 year-end, needing 2–3 quarters to stabilize.

Aalap Patel: "We had a very healthy visibility of inquiries, which was in the tune of 2.8 crore 45 days ago, and that has only grown by a couple of million as we speak today. However, in terms of conversion, we are still awaiting conversion of these inquiries into orders."

Capacity Utilization: The Real Margin Lever

• The 2019 benchmark: In 2019, capacity utilization was close to 90% across filtration & drying and the Anand glass line plant. The company is not there yet but believes the trend over the next 6–12 months can close the gap.
• Q4 exit targets: Glass line at 80%, filtration & drying at 85–90%, heat transfer at 65–70% by Q4 exit. Higher utilization is the primary driver of margin expansion.
• Technology edge vs 2019: The key difference now is technology: on filtration & drying, the company already has an edge, and it aims to build the same in glass line over the medium to long term.

Nilesh Ganjwala: "We are currently not there, and I'll be honest with that. But we do believe that if this trend continues for the next 6 to 12 months, we will be there."

Heat Transfer & Kinam: The Growth Engine

• Kinam trajectory: Substantial top and bottom line growth expected this year after FY25's foundation-building. Stable annual EBIT margins targeted at 20–22%.
• Oil & gas track record: A large oil and gas order has been largely dispatched, adding to credentials. Active conversations underway for similar and larger orders, both in India and offshore.
• Petrochemical pipeline: Track record established; working with other companies for similar orders. No real order book yet, but the segment looks very encouraging based on executed work. This is a longer-term horizon play requiring certifications.
• Capability: Technically competent to handle equipment heavier than 100 tons.
• Minority interest structure: Kinam's erstwhile promoters remain actively engaged with 30% ownership; management sees no reason to disturb an arrangement that is working well. 30% of Kinam's profit will continue as minority interest.

Nilesh Ganjwala: "Kinam was always structured from a perspective of having our erstwhile promoters to continue with us, and they actively are engaged in the business, and they have been absolutely wonderful partners."

New Ventures: Glass Fused Steel & Beyond

• Strategic entry: The acquisition marks entry into glass fused steel products and panels, opening opportunities in biogas digester systems, large storage tanks, and architectural facade solutions.
• Biogas and architecture: Both are nascent in India with little or no adoption currently. The company is developing market understanding and plans for both segments; work is ongoing.
• Wastewater and water: A very interesting segment in India, with demand for purified water rising dramatically from new industries like semiconductors and solar.
• No further acquisitions: Management is not looking at anything on the horizon, though they continue to get approached with ideas.

Guidance & Commitments

Key Metrics